Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Complete removal of scalp tumors is crucial, but malignant cases may recur or metastasize, requiring a multidisciplinary approach and close follow-up.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Oncoplastic breast surgery is more cost-effective than standard lumpectomy for large-breasted women despite being more expensive.

Aumolertinib effectively controls lung cancer and improves quality of life.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Erlotinib can cause hair loss and texture changes.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.